Robert Schvarcz
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Liver Diseases and Immunity
- Liver Disease and Transplantation
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 40
- Hepatitis C virus research 39
- Liver Diseases and Immunity 8
- Epidemiology 30
- Liver Disease Diagnosis and Treatment 21
- Hepatitis B Virus Studies 20
- Co-authors
- Ola Weiland (28 shared papers)Annette Bruchfeld (7 shared papers)Olle Reichard (7 shared papers)Karin Lindahl (8 shared papers)Jan Andersson (2 shared papers)Lars Ståhle (4 shared papers)Aril Frydén (13 shared papers)Gunnar Norkrans (12 shared papers)
- Journals
- Journal of Hepatology (6 papers)Journal of Viral Hepatitis (6 papers)Therapeutic Drug Monitoring (3 papers)Hepatology (3 papers)Journal of Medical Virology (2 papers)
- Partner nations
- SwedenUnited StatesChina
In The Last Decade
Robert Schvarcz
47 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 97
- Hepatology 1.8k
- Epidemiology 1.6k
- Transplantation 63
- Rheumatology 315
- Infectious Diseases 299
Countries citing papers authored by Robert Schvarcz
This map shows the geographic impact of Robert Schvarcz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Schvarcz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Schvarcz more than expected).
Fields of papers citing papers by Robert Schvarcz
This network shows the impact of papers produced by Robert Schvarcz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Schvarcz. The network helps show where Robert Schvarcz may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Schvarcz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 227 | |
| 2 | 2005 | 169 | |
| 3 | 1997 | 161 | |
| 4 | 2002 | 113 | |
| 5 | 2001 | 109 | |
| 6 | 2005 | 96 | |
| 7 | 1995 | 94 | |
| 8 | 1995 | 90 | |
| 9 | 2004 | 87 | |
| 10 | 1997 | 79 | |
| 11 | Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience. | 1995 | 64 |
| 12 | 1989 | 63 | |
| 13 | 1993 | 59 | |
| 14 | 1990 | 56 | |
| 15 | 1990 | 54 | |
| 16 | 2000 | 50 | |
| 17 | 1997 | 49 | |
| 18 | 2000 | 46 | |
| 19 | 1995 | 41 | |
| 20 | 1991 | 41 |
About Robert Schvarcz
Robert Schvarcz is a scholar working on Hepatology, Epidemiology, Rheumatology, Infectious Diseases and Molecular Biology, having authored 48 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (39 papers), Liver Disease Diagnosis and Treatment (21 papers), Hepatitis B Virus Studies (20 papers), Systemic Lupus Erythematosus Research (9 papers), Liver Diseases and Immunity (8 papers), HIV/AIDS drug development and treatment (5 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Protein purification and stability (2 papers). The work is most often cited by research in Hepatology (1.8k citations), Epidemiology (1.6k citations), Transplantation (63 citations), Rheumatology (315 citations) and Infectious Diseases (299 citations). Robert Schvarcz has collaborated with scholars based in Sweden, United States and China. Frequent co-authors include Ola Weiland, Annette Bruchfeld, Olle Reichard, Karin Lindahl, Jan Andersson, Lars Ståhle, Aril Frydén, Gunnar Norkrans, Hans Glaumann and Elisabeth Ståhle. Their work appears in journals such as Journal of Hepatology, Journal of Viral Hepatitis, Therapeutic Drug Monitoring, Hepatology and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.